Merck Serono has provided an update on the redeployment of its Geneva-based staff, 100 days after announcing its decision to close the site. As of Sept. 28, job prospects have been clarified for more than 500 employees, or 40% of Geneva-based employees:
Merck Serono said the number of staff who already have found alternative employment may be even higher, as employees are under no obligation to report their employment status to the company.
“Obviously, we hope that more employees will accept the transfer offers that we have made and that the various ongoing contacts and initiatives will rapidly lead to new jobs for the others,” said François Naef, chairman of the board of directors of Merck Serono.
Since the announcement of the plan to close its Geneva site, Merck Serono has implemented several initiatives designed to identify redeployment opportunities for its staff, in particular:
The first results from these various initiatives have been announced, notably: